Today: 19 June 2026

Ondas (ONDS) stock rises after $1 billion above-market financing — here’s what traders are parsing

Ondas (ONDS) stock rises after $1 billion above-market financing — here’s what traders are parsing

Ondas Holdings shares rose about 3% to $14.44 midday Friday after the company priced a $1 billion stock-and-warrant offering at $16.45 per share, a 17.5% premium to the prior close. The deal includes 19 million shares and pre-funded warrants tied to 60.79 million common stock equivalents. An SEC filing also disclosed Sentry CS, acquired in November, posted a $13.51 million net loss on $11.35 million sales in 2024.
9 January 2026
·
Chevron stock rises on Venezuela export scramble as White House talks loom

Chevron stock rises on Venezuela export scramble as White House talks loom

Chevron shares rose 1.5% to $161.57 in midday trading Friday as the company, Vitol, and Trafigura compete for U.S. deals involving Venezuelan crude, sources said. Chevron is in talks with the U.S. government to expand its Venezuela sanctions license. Oil prices climbed, with Brent at $62.49 a barrel. Investors await Chevron’s Jan. 30 results and any update on its Venezuela operations.
9 January 2026
·
UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWM Holdings shares surged 14% to $5.36 Friday after President Trump ordered $200 billion in mortgage-bond purchases to lower borrowing costs. Over 22 million shares traded. CEO Mat Ishbia’s SFS Holding sold nearly 1.9 million shares earlier in the week at $4.43–$4.70. Investors await inflation and mortgage-rate data for further direction.
9 January 2026
··
AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie shares fell 0.8% to $222.35 after the company cut its 2025 profit outlook and denied takeover talks with Revolution Medicines. AbbVie now expects fourth-quarter adjusted EPS of $2.61–$2.65, down from $3.32–$3.36, citing a $1.3 billion pre-tax acquired R&D expense. Wolfe Research downgraded the stock to “Peer Perform.” AbbVie said results for the quarter ended Dec. 31 are not yet final.
9 January 2026
··
Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push

Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push

Ford shares dropped 1.5% to $14.19 Friday, retracing gains from Thursday’s Piper Sandler upgrade. Traders are watching for Ford’s Feb. 10 earnings, with focus on EV spending and software revenue. The company plans to launch Level 3 driver-assist in 2028, but pricing and rollout details remain undecided. Broader market sentiment was shaped by a weaker U.S. jobs report and rate cut speculation.
9 January 2026
···
Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

Oklo shares jumped 11% after announcing a deal with Meta to develop a 1.2-gigawatt nuclear campus in Ohio. Meta also signed long-term nuclear power agreements with Vistra and TerraPower as AI drives up electricity demand. Investors are watching for updates on permits, funding, and Oklo’s next quarterly report. Trading volume in Oklo surged to 22.1 million shares.
9 January 2026
···
Northrop Grumman stock jumps 4% as Trump payout order shakes defense sector, new contracts land

Northrop Grumman stock jumps 4% as Trump payout order shakes defense sector, new contracts land

Northrop Grumman shares climbed 4.2% to $615.86 Friday, rebounding after a sharp drop earlier in the week triggered by Trump’s order tying dividends, buybacks, and executive pay to weapons delivery schedules. The company announced a $94.3 million Navy missile contract and a $231.5 million Marine Corps drone award. Defense stocks have swung on policy signals and new contract wins.
9 January 2026
··
Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra Corp shares jumped 11.4% to $167.81 after announcing 20-year nuclear power purchase agreements with Meta Platforms covering over 2,600 MW from three plants. The contracts begin deliveries in late 2026 and could boost Vistra’s adjusted free cash flow by up to 17% once fully in place. Meta also signed nuclear deals with two other firms. Vistra stock remains below its September high of $219.82.
9 January 2026
······
NASA orders SpaceX Crew-11 home early from ISS after undisclosed astronaut medical issue, spacewalk canceled

NASA orders SpaceX Crew-11 home early from ISS after undisclosed astronaut medical issue, spacewalk canceled

NASA will return SpaceX’s Crew-11 from the International Space Station ahead of schedule after a crew member developed a serious medical condition, officials said Thursday. The astronaut is stable, but NASA said the ISS lacks the capability to diagnose and treat the issue. The agency is reviewing return dates and coordinating with SpaceX and partners to advance the Crew-12 launch. NASA has not disclosed the astronaut’s identity or medical details.
9 January 2026
·
Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin shares rose 4.2% to $539.96 Friday after President Trump signed an executive order tying dividends, buybacks, and executive pay to weapons delivery schedules. Defense stocks gained as Trump called for a $1.5 trillion 2027 military budget, far above the $901 billion set for 2026. Lockheed paid $2.3 billion each in dividends and buybacks last year. The company reports quarterly results Jan. 29.
9 January 2026
···
Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies India’s IPO share allotment is set for Jan. 9 after the offer drew 768 times subscription, with retail and non-institutional investors leading demand, BSE data showed. Shares are scheduled to list Jan. 13 on the BSE SME platform. Grey market prices hovered near 113 rupees, about 40% above the issue price, though this market is unregulated. The IPO was a fresh issue of 3.6 million shares at 76–81 rupees each.
9 January 2026
··
1 … 934 935 936 937 938 … 2,083

Stock Market Today

  • CareTrust REIT (CTRE) Reports Robust EPS and Revenue Growth, Nears Technical Breakout
    June 19, 2026, 9:16 AM EDT. CareTrust REIT Inc (NYSE:CTRE), a healthcare Real Estate Investment Trust (REIT), posted 63% earnings per share (EPS) growth and 58% revenue growth, signaling strong financial performance. The company also earned a technical setup rating of 7 out of 10 by ChartMill, indicating a favorable position near support levels that could lead to a potential breakout. These metrics highlight CareTrust's expanding footprint in the healthcare property sector amid improving market conditions.

Latest articles

Rocket Lab Drops Even After Nasdaq-100 Nod, SpaceX IPO Buzz Fades

Rocket Lab holds ground ahead of Nasdaq-100 debut after selloff led by SpaceX

19 June 2026
Rocket Lab enters the Nasdaq-100 before Monday’s open, positioning shares for potential index-driven demand after closing at $107.24 Thursday, up 4.7% for the week despite sector volatility and a SpaceX-driven shakeout; KeyBanc upgraded the stock to Overweight with a $135 target, citing strong revenue growth and a $2.2 billion backlog as the company faces a key test with its Neutron rocket still in development.
VW Shares Drop as Dividend Date Passes, Blume Steps Up Cost Cuts

VW Shares Drop as Dividend Date Passes, Blume Steps Up Cost Cuts

19 June 2026
Volkswagen preferred shares dropped 4.24% to €80.53 after trading ex-dividend, as investors weighed a €5.26 payout and CEO Oliver Blume’s warning that the next years are “critical” for cost cuts, capacity reductions, and returns, with 50,000 job cuts planned and over €6 billion in annual savings targeted by 2030.
ASML drops after China chip-tool issue interrupts AI rally

ASML drops after China chip-tool issue interrupts AI rally

19 June 2026
ASML shares fell 0.6% in Amsterdam after the company denied shipping extreme ultraviolet chipmaking machines or parts to China, following a Bloomberg report on U.S. export-control concerns, interrupting an AI-driven rally; China accounted for 33% of ASML sales in 2025, with the company expecting that share to drop to 20% this year amid ongoing policy risks.
Go toTop